For less-familiar targets, we recommend a layered validation strategy. Start with dilution parallelism and spike recovery in your matrix, then confirm biological plausibility using a known perturbation (or a positive control sample if available). If you have access, cross-check a subset with an orthogonal method (e.g., western blot or targeted proteomics). Because this is a quantitative colorimetric sandwich ELISA, these steps help ensure the measured signal reflects MST1L rather than matrix-driven background.
You can run them side-by-side operationally, but direct numeric comparison between different targets is not meaningful because each assay has its own antibody pair, calibration, and response characteristics. The best use is comparative biology within each target: how MST1L changes across conditions, and how MST1 changes across the same conditions. If you want to relate them, compare patterns (direction and relative magnitude) rather than absolute concentrations.
When signals are near the low end, improve detectability by (1) concentrating samples when feasible, (2) minimizing dilution and avoiding unnecessary buffer additives, and (3) increasing replicate number to stabilize estimates. Also ensure samples are handled to preserve protein integrity-aliquot and avoid repeated freeze-thaw. Finally, keep samples within the standard curve and avoid extrapolation; if needed, redesign the sampling strategy to collect higher-yield matrices or timepoints.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.